Work

Endovascular Management of Ascending Aortic Disease in Patients Unsuitable for Open Repair

Year: 2026
Type: article
Study design: Case Report
Abstract: BACKGROUND While thoracic endovascular aortic repair (TEVAR) of the descending aorta has been widespread for several decades, TEVAR for ascending aortic pathology has not been widely implemented. This technique is a promising alternative to medical therapy when patient-specific circumstances prohibit open repair. METHODS We included patients from 2019 to 2025 who underwent ascending TEVAR repair for any indication at our single institution. We characterize the presentation, operative techniques, post-operative course, and follow-up for each patient. RESULTS From 2019 to 2025, we performed seven ascending aortic TEVARs for four acute type A aortic dissections and three aortic pseudoaneurysms. Technical success was achieved in all patients. Six patients survived to hospital discharge. Among these six, the mean intensive care unit length of stay was 2.83 days. No patients had clinically significant strokes peri-operatively. One patient required an open TEVAR explant and repair about six months after index TEVAR and recovered well from the reintervention. Among all seven patients, 5/7 are alive in follow-up ranging from 6-months to 3-years postoperatively. CONCLUSIONS In our experience, TEVAR is an effective alternative to medical management or palliative care for ascending aortic pathology when open repair is of prohibitive risk.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $975
OpenAlex ID: W7203985151
FWCI:
Cites: 7
Cited by:
Related to: 10